These findings underpin the notion that artificially increasing the ‘functional dose’ of PTEN, even slightly, could elicit a significant reduction tumor burden and/or the rate of caner progression by restoring PTEN tumor-suppressive functions, thus presenting an attractive therapeutic approach. Here, PTEN is linked to neoplasm.